# Study of Radiation Therapy in Combination With Xeloda, for Initially Metastatic, Low and Middle Rectal Cancer

> **NCT03634202** · NA · TERMINATED · sponsor: **Institut Cancerologie de l'Ouest** · enrollment: 9 (actual)

## Conditions studied

- Rectal Cancer
- Metastasis
- Radiotherapy

## Interventions

- **COMBINATION_PRODUCT:** IMRT + oral chemotherapy

## Key facts

- **NCT ID:** NCT03634202
- **Lead sponsor:** Institut Cancerologie de l'Ouest
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2015-05-05
- **Primary completion:** 2018-12-10
- **Final completion:** 2018-12-10
- **Target enrollment:** 9 (ACTUAL)
- **Why stopped:** the study was stopped for lack of inclusion
- **Last updated:** 2019-05-15


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03634202

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03634202, "Study of Radiation Therapy in Combination With Xeloda, for Initially Metastatic, Low and Middle Rectal Cancer". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT03634202. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*